291 related articles for article (PubMed ID: 24843137)
1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity.
Chiarlone A; Bellocchio L; Blázquez C; Resel E; Soria-Gómez E; Cannich A; Ferrero JJ; Sagredo O; Benito C; Romero J; Sánchez-Prieto J; Lutz B; Fernández-Ruiz J; Galve-Roperh I; Guzmán M
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8257-62. PubMed ID: 24843137
[TBL] [Abstract][Full Text] [Related]
2. The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.
Blázquez C; Chiarlone A; Bellocchio L; Resel E; Pruunsild P; García-Rincón D; Sendtner M; Timmusk T; Lutz B; Galve-Roperh I; Guzmán M
Cell Death Differ; 2015 Oct; 22(10):1618-29. PubMed ID: 25698444
[TBL] [Abstract][Full Text] [Related]
3. Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors.
Ruiz-Calvo A; Maroto IB; Bajo-Grañeras R; Chiarlone A; Gaudioso Á; Ferrero JJ; Resel E; Sánchez-Prieto J; Rodríguez-Navarro JA; Marsicano G; Galve-Roperh I; Bellocchio L; Guzmán M
Cereb Cortex; 2018 Jan; 28(1):307-322. PubMed ID: 29121220
[TBL] [Abstract][Full Text] [Related]
4. Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony.
Sales-Carbonell C; Rueda-Orozco PE; Soria-Gómez E; Buzsáki G; Marsicano G; Robbe D
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):719-24. PubMed ID: 23269835
[TBL] [Abstract][Full Text] [Related]
5. Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.
Martín-García E; Bourgoin L; Cathala A; Kasanetz F; Mondesir M; Gutiérrez-Rodriguez A; Reguero L; Fiancette JF; Grandes P; Spampinato U; Maldonado R; Piazza PV; Marsicano G; Deroche-Gamonet V
Neuropsychopharmacology; 2016 Aug; 41(9):2192-205. PubMed ID: 26612422
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice.
Terzian AL; Micale V; Wotjak CT
Eur J Neurosci; 2014 Jul; 40(1):2293-8. PubMed ID: 24698342
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
Saez TM; Aronne MP; Caltana L; Brusco AH
J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
[TBL] [Abstract][Full Text] [Related]
8. The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum.
Martella G; Meringolo M; Trobiani L; De Jaco A; Pisani A; Bonsi P
Eur J Neurosci; 2018 Mar; 47(6):701-708. PubMed ID: 28921757
[TBL] [Abstract][Full Text] [Related]
9. GABAergic and cortical and subcortical glutamatergic axon terminals contain CB1 cannabinoid receptors in the ventromedial nucleus of the hypothalamus.
Reguero L; Puente N; Elezgarai I; Mendizabal-Zubiaga J; Canduela MJ; Buceta I; Ramos A; Suárez J; Rodríguez de Fonseca F; Marsicano G; Grandes P
PLoS One; 2011; 6(10):e26167. PubMed ID: 22022550
[TBL] [Abstract][Full Text] [Related]
10. Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration.
Häring M; Kaiser N; Monory K; Lutz B
PLoS One; 2011; 6(11):e26617. PubMed ID: 22069458
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.
Domenici MR; Azad SC; Marsicano G; Schierloh A; Wotjak CT; Dodt HU; Zieglgänsberger W; Lutz B; Rammes G
J Neurosci; 2006 May; 26(21):5794-9. PubMed ID: 16723537
[TBL] [Abstract][Full Text] [Related]
12. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
Musella A; Sepman H; Mandolesi G; Gentile A; Fresegna D; Haji N; Conrad A; Lutz B; Maccarrone M; Centonze D
Neuropharmacology; 2014 Apr; 79():567-72. PubMed ID: 24440366
[TBL] [Abstract][Full Text] [Related]
13. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic Innervation onto Striatal Neurons Potentiates GABAergic Synaptic Output.
Paraskevopoulou F; Herman MA; Rosenmund C
J Neurosci; 2019 Jun; 39(23):4448-4460. PubMed ID: 30936241
[TBL] [Abstract][Full Text] [Related]
15. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
Rey AA; Purrio M; Viveros MP; Lutz B
Neuropsychopharmacology; 2012 Nov; 37(12):2624-34. PubMed ID: 22850737
[TBL] [Abstract][Full Text] [Related]
16. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.
Steindel F; Lerner R; Häring M; Ruehle S; Marsicano G; Lutz B; Monory K
J Neurochem; 2013 Mar; 124(6):795-807. PubMed ID: 23289830
[TBL] [Abstract][Full Text] [Related]
17. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
18. A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices.
Maya-López M; Rubio-López LC; Rodríguez-Alvarez IV; Orduño-Piceno J; Flores-Valdivia Y; Colonnello A; Rangel-López E; Túnez I; Prospéro-García O; Santamaría A
Neurotox Res; 2020 Jan; 37(1):126-135. PubMed ID: 31286434
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions.
Ruehle S; Remmers F; Romo-Parra H; Massa F; Wickert M; Wörtge S; Häring M; Kaiser N; Marsicano G; Pape HC; Lutz B
J Neurosci; 2013 Jun; 33(25):10264-77. PubMed ID: 23785142
[TBL] [Abstract][Full Text] [Related]
20. Anatomical characterization of the cannabinoid CB
Gutiérrez-Rodríguez A; Puente N; Elezgarai I; Ruehle S; Lutz B; Reguero L; Gerrikagoitia I; Marsicano G; Grandes P
J Comp Neurol; 2017 Feb; 525(2):302-318. PubMed ID: 27339436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
